Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-10

Clinical Trial Update: Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

A safety study of umbilical cord blood for pediatric traumatic brain injury (Phase 1/Phase 2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Blood

Snippet

Sponsor: Charles Cox | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: WITHDRAWN